Glooko enhances health outcomes of people with diabetes through personalized, intelligent, connected care platforms. Our proven technologies make lives better by revolutionizing the connection between patients and providers, as well as driving patient engagement and adherence via digital insights. Glooko solutions are globally deployed in more than 30 countries, 10,000+ clinical locations and integrated with over 200 devices.
The order this company entered each market — oldest to newest
Sign up to see the full signal feed
How Glooko's international expansion compares to its competitors
GlookoYouBars show relative size across the companies compared.
5 metrics| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 GlookoYou | 0 | 0 | 0% | 0 | 32 |
No new roles opened in this window.
Gothenburg, Västra Götaland County, Sweden · last yr.
Product Owner
43 technologies detected across the stack.
2 active campaigns across 1 market.
Active
ActiveNo media coverage in this window.
Technological advancements in diabetes management offer potential but also challenges. Clinicians and patients face data overload and burnout, necessitating better integration of technology in care.
Glooko and Hedia launch integrated solution for personalized insulin dosing advice, improving diabetes care and enhancing provider insights in the UK and Europe.
Glooko and Hedia launch an interoperable solution combining connected care, remote patient monitoring, and digital therapeutics for personalized insulin dosing support for diabetes patients.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Glooko's business, markets, and growth signals.
“We reach accounts the week they land in-market — not the quarter after.”
Book a walkthrough of the movement map with our team.
Pubrio turns expansion signals across 200+ markets into one live graph, so revenue teams see which companies are entering new markets, and act on the timing.
© 2026 Pubrio. All rights reserved.
